###begin article-title 0
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival
###end article-title 0
###begin p 1
###xml 31 48 31 48 <email xmlns:xlink="http://www.w3.org/1999/xlink">klc1@columbia.edu</email>
###xml 72 89 72 89 <email xmlns:xlink="http://www.w3.org/1999/xlink">martinsg@cshs.org</email>
CORRESPONDENCE Kathryn Calame: klc1@columbia.edu OR Gislaine A. Martins martinsg@cshs.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with a T cell-specific deletion of Prdm1, encoding Blimp-1, have aberrant T cell homeostasis and develop fatal colitis. In this study, we show that one critical activity of Blimp-1 in T cells is to repress IL-2, and that it does so by direct repression of Il2 transcription, and also by repression of Fos transcription. Using these mechanisms Blimp-1 participates in an autoregulatory loop by which IL-2 induces Prdm1 expression and thus represses its own expression after T cell activation, ensuring that the immune response is appropriately controlled. This activity of Blimp-1 is important for cytokine deprivation-induced T cell death and for attenuating T cell proliferation in antigen-specific responses both in vitro and in vivo.
###end p 3
###begin p 4
G.A. Martins' present address is Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
###end p 4
###begin p 5
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
The terminal differentiation of effector lymphocytes after encounter with antigen is a complex and tightly regulated process that ensures rapid, but limited, immune responses. Transcription factors play crucial regulatory roles in the differentiation processes that culminate in the formation of effector and memory B and T cells (1, 2).
###end p 5
###begin p 6
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
The transcriptional repressor B lymphocyte-induced maturation protein-1 (Blimp-1) is one of the few transcription factors known to be crucial for regulating B lymphocyte terminal differentiation. Blimp-1 is required (3) and sufficient (4) for the formation of fully functional antibody-secreting plasma cells and for maintenance of long-lived plasma cells in the bone marrow (5).
###end p 6
###begin p 7
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm-1</italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 514 519 <span type="species:ncbi:10090">mouse</span>
Blimp-1 is a SET domain and a zinc finger-containing transcriptional repressor encoded by the Prdm-1 gene. Transcriptional repression by Blimp-1 is mediated by repressive modifications in chromatin structure, through recruitment of Groucho family transcriptional corepressors, and chromatin-modifying enzymes (for review see [6]). In addition to its crucial role in the differentiation of plasma cells, Blimp-1 has critical functions in embryonic development (7, 8), and targeted deletion of the Prdm1 gene in the mouse is embryonically lethal (9). Blimp-1 is also required for terminal differentiation of several nonlymphoid cell lineages in adult organisms (for review see [6]).
###end p 7
###begin p 8
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 315 316 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
Recently, a role for Blimp-1 in T cell differentiation was demonstrated in two laboratories (10, 11). After T cell receptor (TCR) stimulation, both CD4+ and CD8+ T lymphocytes express Blimp-1 mRNA in amounts comparable to that in fully mature plasma cells. Blimp-1 mRNA is also expressed at high levels in Foxp3+CD4+ regulatory T cells. Conditional deletion of Blimp-1 in T cells results in profound alterations of T cell homeostasis and function and culminates in the spontaneous development of fatal colitis (10, 11). Blimp-1-deficient CD4+ regulatory T cells (T reg cells) are partially dysfunctional, as they perform properly in in vitro immunosupression assays and in one colitis model in vivo (11), but fail to inhibit chemically induced colitis in WT mice (10).
###end p 8
###begin p 9
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
TCR stimulation of Blimp-1-deficient CD4+ T cells in vitro results in hyperresponsiveness that is revealed by robust proliferation in suboptimal stimulatory conditions and increased numbers of IL-2 producers, indicating that Blimp-1 is a negative regulator of IL-2 production (10). This idea is also reinforced by two recent observations: (a) Blimp-1 and IL-2 expression upon TCR stimulation are inversely correlated, and (b) enforced expression of Blimp-1 in T cells represses IL-2 production upon TCR stimulation (12, 13).
###end p 9
###begin p 10
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 664 665 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
IL-2 was initially identified as an autocrine cytokine necessary for in vitro expansion of T cells (14). Subsequent studies indicated a role for IL-2 in promoting T cell expansion, survival, effector differentiation, and memory cell survival via promotion of IL-7R expression (15). Indeed, the stimulatory properties of IL-2 make it a therapeutic target, especially in AIDS and cancer, where IL-2 administration promotes T cell expansion in vivo (15, 16). IL-2 has also been shown to participate in the contraction of inflammatory responses, by programming activated CD4+ T cells for apoptosis (17, 18) and promoting the growth and survival of the innate CD4+FoxP3+T reg cells (15). Because of these effects, IL-2- or IL-2R-deficient mice exhibit a multifaceted autoimmune phenotype characterized by multiorgan inflammation, absence of T reg cells, and accumulation of autoreactive T cells (for review see [15]).
###end p 10
###begin p 11
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
Interestingly, IL-2 represses its own expression in a classical negative-feedback loop that functions in a STAT-5-dependent manner (19). This finding, together with the observation that IL-2 is a potent inducer of Blimp-1 expression in T cells (12), led to the suggestion that Blimp-1 plays important roles in IL-2 autoregulation.
###end p 11
###begin p 12
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
We have investigated this hypothesis, and report that Blimp-1 directly represses the Il2 gene and indirectly represses Il2 by repressing Fos, which encodes Fos; Fos is a component of AP-1, a strong activator of Il2. As a consequence of the increased production of IL-2 in the absence of Blimp-1, CD4+ T cell proliferate more upon antigen-specific stimulation and are more resistant to cytokine deprivation-induced cell death. Attenuation of IL-2 production by Blimp-1 plays a role in an antigen-specific response in vivo. Thus, one important function of Blimp-1 in T cells is to attenuate IL-2 production upon antigen stimulation, by both direct and indirect gene repression.
###end p 12
###begin title 13
RESULTS AND DISCUSSION
###end title 13
###begin title 14
Blimp-1 attenuates IL-2 expression in the primary response
###end title 14
###begin p 15
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 857 865 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 356 371 <span type="species:ncbi:10090">transgenic mice</span>
We have previously reported that lack of Blimp-1 results in increased proliferation and IL-2 production after polyclonal TCR stimulation (10). To further understand the mechanisms by which Blimp-1 regulates IL-2 production, we evaluated the kinetics of IL-2 production in an antigen-specific context. Blimp-1 conditional KO (CKO) mice were bred to OT2 TCR transgenic mice to generate antigen-specific, Blimp-1-sufficient (Ctrl) and -deficient (CKO) CD4+ T cells. When naive (CD44low) OT2 CD4+ cells were stimulated in vitro with APCs and cognate antigen, the percentage of IL-2-producing cells was significantly higher in the CKO than in the Ctrl cultures in all time points evaluated. In agreement with results from polyclonal stimulation (10), TCR restimulation 3 d after primary activation also resulted in more IL-2-producing cells in the CKO cultures (Fig. 1 A). CKO cells proliferated more robustly, especially when antigen was provided in lower doses (Fig. S1 A, available at ). Thus, Blimp-1 attenuates proliferation and the number of IL-2-producing cells upon antigen-specific stimulation, and attenuation of IL-2 production by Blimp-1 can be observed at the time of primary stimulation.
###end p 15
###begin p 16
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of Blimp-1 and IL-2.</bold>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 283 284 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 393 394 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 679 680 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
Expression of Blimp-1 and IL-2. (A) Production of IL-2 by naive CD4+ OT2 Blimp-1-sufficient (Ctrl) and -deficient (CKO) cells stimulated with 0.1 muM OVA and APC (determined as described in Materials and methods). Data shown is the percentage of IL-2-producing cells in the live, CD4+ cell gate. (B) Steady-state Blimp-1 and IL-2 mRNA (determined by quantitative real-time PCR) in naive WT CD4+ T cells stimulated as described in Materials and methods. (C) Few, if any, Blimp-1-expressing cells produce IL-2. Lymph node and spleen cells from Blimp-1-GFP reporter mice were stimulated (top) or restimulated (bottom) and stained for IL-2 and GFP. Plots show GFP and IL-2 in the CD4+ cells. Specificity of GFP staining is shown on the top left.
###end p 16
###begin p 17
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 604 605 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 772 780 772 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 893 894 893 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1021 1022 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1193 1201 1181 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1395 1403 1383 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 833 838 <span type="species:ncbi:10090">mouse</span>
IL-2 is known to induce Blimp-1 in B cells (4), and most of the induction of Blimp-1 mRNA and protein upon T cell activation has been shown to depend on IL-2 production (12). Consistent with our observation of increased IL-2 production in Blimp-1 CKO T cells (Fig. 1 A) (10), forced expression of Blimp-1 in T cells decreases expression of IL-2 (12, 13), and IL-2 causes its own down-regulation (12, 19). Given these complicated interactions, we investigated the kinetics of Blimp-1 and IL-2 expression in normal T cells, measuring steady-state mRNA levels. At days 1 and 2 after stimulation of naive CD4+ T cells in vitro, IL-2 steady-state mRNA is more strongly induced than Blimp-1 mRNA. However, by day 3, Blimp-1 mRNA increases significantly and IL-2 mRNA decreases (Fig. 1 B). To study this at the single-cell level, we used a mouse in which Blimp-1 mRNA expression is reported by EGFP (7). Total spleen cells were stimulated in vitro and analyzed for IL-2 and GFP expression. 1 d after stimulation, <10% of the CD4+ T cells expressed GFP, whereas approximately5% of cells expressed IL-2. 3 d after stimulation, GFP expression increased to 17%, whereas IL-2 expression decreased to <3% (Fig. 1 C, top right). Restimulation on day 3 resulted in increased expression of both IL-2 protein and Blimp-1 mRNA, and addition of IL-2 amplified Blimp-1 expression, while decreasing IL-2 production (Fig. 1 C, bottom). Strikingly, in all time points, very few cells were double-positive for GFP and Blimp-1.
###end p 17
###begin p 18
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 349 364 349 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and C</xref>
###xml 444 452 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
Previous studies show that IL-2 production is tightly regulated (20, 21), and that even under optimal conditions not all T cells in a population will acquire the competence to transcribe the Il2 gene and synthesize IL-2 upon primary stimulation (22). The negative correlation between Blimp-1 expression and IL-2 production at the single-cell level (Fig. 1, B and C), along with the observation that more cells make IL-2 when Blimp-1 is absent (Fig. 1 A), provide evidence that expression of Blimp-1 is important in the exclusion of IL-2 production upon TCR stimulation. These results confirm and expand previous data (10, 12), supporting the model that upon T cell activation, most induction of Blimp-1 occurs secondary to IL-2 production and that the induced Blimp-1 participates in a regulatory loop to repress IL-2 expression.
###end p 18
###begin title 19
Blimp-1 is required for cytokine deprivation-induced cell death after activation
###end title 19
###begin p 20
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 227 233 227 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
IL-2 also has important effects on T cell apoptosis (18). After T cell activation, IL-2 production decreases, triggering passive cell death and limiting T cell numbers at the conclusion of an immune response. Because our data (Fig. 1) implicated Blimp-1 in postactivation down-regulation of IL-2, we next investigated whether Blimp-1 also plays a role in passive cell death after IL-2 withdrawal.
###end p 20
###begin p 21
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 428 422 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 675 681 675 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Naive CD4+ T cells from Ctrl or CKO mice were stimulated for 5 d, in optimal conditions, so IL-2 production was maximal and Blimp-1 expression was high in the Ctrl cells. 5 d after stimulation, cells were extensively washed and replated with or without exogenous IL-2. Blimp-1 CKO cells survived better in the absence of exogenous IL-2, and there were two- to threefold more live cells in CKO cultures compared with Ctrl (Fig. 2). Addition of IL-2 at the time of replating abrogated the differences between Ctrl and CKO cells, indicating that the increased IL-2 production in the absence of Blimp-1 was responsible for the increased survival of effector cells in this assay (Fig. 2). Thus, Blimp-1-dependent repression of IL-2 is important for passive cell death at the conclusion of an immune response.
###end p 21
###begin p 22
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Attenuation of IL-2 production by Blimp-1 promotes susceptibility to IL-2 deprivation&#8211;induced cell death.</bold>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 471 472 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 482 483 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Attenuation of IL-2 production by Blimp-1 promotes susceptibility to IL-2 deprivation-induced cell death. Control and CKO naive CD4+ T cells were stimulated with plate-bound alphaCD3, alphaCD28, and IL-2 for 5 d (primary stimulation), washed, and replated in medium only (left) or in the presence of IL-2 (right). Cell death was determined by staining with Annexin V and 7-AAD. Results shown (mean and SEM from two independent experiments) are the percentage of Annexin V- and 7-AAD- cells.
###end p 22
###begin title 23
Lack of Blimp-1 results in increased IL-2 and Fos mRNA
###end title 23
###begin p 24
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 638 646 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1012 1015 1012 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1063 1065 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1158 1161 1154 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1234 1237 1230 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1314 1317 1310 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1419 1422 1415 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1528 1536 1524 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1571 1574 1567 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1717 1719 1713 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1721 1723 1717 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
We wished to understand the molecular mechanism by which Blimp-1 controls IL-2 production. Although the production of IL-2 is regulated transcriptionally and posttranscriptionally (20, 21) because Blimp-1 is a transcriptional repressor, it probably regulates the transcription of the Il2 gene, either directly and/or indirectly. To test this hypothesis, we first analyzed steady-state levels of IL-2 mRNA in cells from Ctrl and CKO mice. Naive CD4+ cells from CKO mice had significantly higher amounts of steady-state IL-2 mRNA than cells from Ctrl mice, before and at later time points after stimulation (days 2 and 3), but not earlier (Fig. 3 A). This suggests that low levels of Blimp-1 in naive cells (10) are sufficient to repress Il2 before activation. Alternatively, or in addition, the repression of Il2 by Blimp-1 in naive cells could be facilitated by the regulatory pathways operating before TCR stimulation, which differ considerably from the ones in place after stimulation (21). Upon activation of Il2 by NFAT, members of AP-1 family and NF-kappaB (21), the relatively low amounts of Blimp-1 are apparently overcome, and Blimp-1 cannot repress Il2. However, as Blimp-1 levels rise, Blimp-1 is once again able to repress Il2 transcription. If higher levels of Blimp-1 are, indeed, required to contain Il2 transcription upon TCR stimulation, it would also explain why restimulation at day 3 results in more Il2 mRNA in Blimp-1 CKO cells, as in these circumstances Blimp-1 expression in WT cells is further elevated (Fig. 1 C; unpublished data). Repression of Il2 by Blimp-1 is also consistent with the recent observation that enforced expression of Blimp-1 represses IL-2 production upon TCR stimulation (12, 13).
###end p 24
###begin p 25
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Blimp-1 deficiency results in increased levels of IL-2 and Fos steady-state mRNA.</bold>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Blimp-1 deficiency results in increased levels of IL-2 and Fos steady-state mRNA. Steady-state IL-2 (A) and Fos (B) mRNA in naive (day 0) and stimulated CD4+ T cells from Control and CKO mice. In A, the middle graph shows steady-state IL-2 mRNA (normalized to 18 S) before and after restimulation. Ratios (CKO/Ctrl) from values in left graphs are shown in the right graphs. Results are representative of three to five experiments.
###end p 25
###begin p 26
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 448 456 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 527 530 527 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 549 552 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
Fos, a component of the AP-1 family of transcription factors, is one of the well-known transcriptional activators of the Il2 gene in T cells (23, 24). Because our previous studies (25) showed that Fos is a direct target of Blimp-1-dependent repression in keratinocytes, we asked if Blimp-1 repressed Fos in T cells. Blimp-1-deficient CD4+ T cells stimulated (as described in Materials and methods) showed increased levels of Fos steady-state mRNA (Fig. 3 B). Thus, Blimp-1 normally down-regulates the steady-state mRNA of both Il2 and its activator Fos.
###end p 26
###begin title 27
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
Blimp-1 directly represses the Il2 and Fos genes
###end title 27
###begin p 28
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 916 919 916 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1447 1448 1447 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1553 1554 1553 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1648 1656 1648 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1751 1759 1751 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1821 1824 1821 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
Preliminary chromatin immunoprecipitation (ChIP) experiments showed increased specific binding of Pol II to the transcription initiation site of the Il2 gene in activated CKO CD4 cells compared with Ctrl cells (unpublished data). Because a direct correlation between Pol II binding and transcription has been previously demonstrated for the Il2 gene (26), this suggested that Blimp-1 directly represses Il2 transcription. To test this hypothesis and identify Blimp-1 response elements, we searched the genomic sequence (plus 10 kb upstream and 10 kb downstream of the transcriptional start site [TSS]) of the mouse and human Il2 genes, looking for Blimp-1 consensus binding sites (CBSs). We found 20 putative CBSs for Blimp-1 in the mouse Il2 gene (Table S1, available at ), and 8 of these sites (-7,252, -5,547, -4,795, -4,765, -4,221, -4,207, -3,982, and -1,861) were contained in an 8.4-kb region upstream of the Il2 TSS, which has been shown to be repressed by Blimp-1 in an in vitro reporter assay (12). We focused our efforts on these sites first; however, some sites were embedded in simple-sequence repeats and we were unable to design primers for efficient amplification of these regions. Thus, sites -3,982, -1,861, in the upstream region of the gene, and +10,215 and a region containing no Blimp-1 consensus sequence (+1,556 to +1,713 bp) relative to the TSS were investigated. We assayed binding of endogenous Blimp-1 by ChIP in WT CD4+ T cells after 6-d stimulation and restimulation in vitro, a condition where Blimp-1 expression is high (6). Out of the 3 Blimp-1 CBSs investigated, only site -1,861 was enriched for Blimp-1 binding (Fig. 4 A). Sites -3,982 and +10,215, as well as the irrelevant site, showed no significant enrichment (Fig. 4 A). Thus, Blimp-1 binds specifically at the site -1,861 of the Il2 gene.
###end p 28
###begin p 29
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Blimp-1 binds to the mouse <italic>Il2</italic> and <italic>Fos</italic> genes.</bold>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 535 538 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 543 546 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 679 682 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 758 761 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 713 718 <span type="species:ncbi:9606">human</span>
###xml 723 728 <span type="species:ncbi:10090">mouse</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:9606">human</span>
Blimp-1 binds to the mouse Il2 and Fos genes. (A) ChIP of endogenous Blimp-1 bound in various regions of the Il2 and Fos genes. WT purified CD4+ T cells were stimulated in vitro for 6 d, restimulated with PMA and ionomycin for 4 h, and cross-linked for ChIP. Data represent fold enrichment of alphaBlimp-1 antibody over control antibody. Snail3 is used as a negative control. NR is a region containing no Blimp-1 consensus sequence. Results shown are the mean and SEM from four to five different experiments. (B) Representation of the Il2 and Fos mouse genes, with the sites shown in A marked. Sites enriched for Blimp-1 binding are marked with asterisks. The -4,990 site at the Fos gene is conserved between the human and mouse genes. No sites found at the Il2 gene are conserved between mouse and human.
###end p 29
###begin p 30
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 355 363 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
Previous studies showed that an 8.4-kb region of the Il2 promoter, containing this site, conferred proper expression in transgenic cells (27) and forced expression of Blimp-1 decreased expression of this transgene (12). Although another potential Blimp-1 CBS is present in the 8.4-kb region (site -3,982), this site does not seem to bind Blimp-1 in vivo (Fig. 5 A). Thus, the -1,862-bp site is likely to mediate repression of Il2 by Blimp-1, although other currently untested sites in the 8.4-kb regulatory region (Table S1) may also contribute.
###end p 30
###begin p 31
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of Blimp-1 results in increased proliferation and IL-2 production in vivo.</bold>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 438 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 742 745 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 750 753 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
Lack of Blimp-1 results in increased proliferation and IL-2 production in vivo. CFSE-labeled naive Ctrl or CKO CD45.2 OT2 CD4+ T cells were injected i.v. into CD45.1 congenic WT mice. 2 d later, mice were immunized i.v. with antigen-pulsed APCs, and 5 d later, lymph nodes were collected and proliferation (A) and IL-2 production (B) were analyzed. Data in B are the mean (+/- SEM) of the percentage of IL-2-producing cells in the CD45-2+ gate in four different experiments. (C) Schematic representation of Blimp-1 participation in IL-2 autoregulation. Induction/activation of N-FAT, AP-1, and NF-kappaB upon TCR and CD28 stimulation leads to IL-2 transcription. IL-2 acting via STAT-5 leads to Blimp-1 expression. Blimp-1 then represses the Il2 and Fos genes, inhibiting IL-2 production.
###end p 31
###begin p 32
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1&#8211;3</xref>
###xml 252 252 252 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"/>
###xml 252 252 252 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig"/>
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
We also evaluated Blimp-1 binding to previously identified sites in Fos (25). Sites located at -179 and -4,990 bp from the TSS of mouse Fos are enriched for Blimp-1 binding in CD4+ T lymphocytes. These results, together with previous results (Figs. 1-3), demonstrate that Blimp-1 directly represses transcription of Il2 and the Il2 activator Fos.
###end p 32
###begin p 33
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
We conclude that Blimp-1 attenuates IL-2 production both directly, by repression of the Il2 gene, and indirectly, by repression of Fos. Nevertheless, the contribution of Fos to the overall increase in Il2 transcription in the CKO cells is difficult to determine. Enforced expression of Fos in T cells caused elevated IL-2 production (28); however, deletion of Fos alone is insufficient to decrease IL-2 production (29), and the effects of Fos in regulating proliferation can only be observed when both FosB and Fos are missing (for review see [30]).
###end p 33
###begin title 34
Lack of Blimp-1 leads to increased IL-2 production in vivo
###end title 34
###begin p 35
###xml 10 19 10 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1&#8211;2</xref>
###xml 19 19 19 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"/>
###xml 24 30 24 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 831 846 831 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A and B</xref>
###xml 943 951 943 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 1030 1031 1018 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1084 1085 1072 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1150 1158 1138 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1194 1195 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1284 1290 1272 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
Our data (Figs. 1-2 and Fig. 4), and that of others (12, 19), show that the transient nature of IL-2 production after T cell activation depends on induction of Blimp-1 by IL-2 and subsequent Blimp-1-dependent repression of IL-2 production via repression of Il2 and Fos. To explore the role of Blimp-1-dependent repression of IL-2 in vivo, we transferred Ctrl and CKO CFSE-labeled naive CD4+ OT2 (CD45.2) into allotype congenic recipients (C57BL/6 SJ CD45.1), and then immunized the recipients with dendritic cells pulsed with OVA peptide. 5 d later, cells were recovered from lymph nodes of recipients and restimulated in vitro, and IL-2 production was evaluated in the CD45.2+ population by intracellular cytokine staining. At this time point, both proliferation and IL-2 production were more pronounced in the Blimp-1 CKO cells (Fig. 5, A and B). Approximately twofold more Blimp-1 CKO cells entered cell cycle compared with the Ctrl cells (Fig. 5 A). In addition, in mice injected with CKO cells, approximately40% of the CD45.2+ cells were producing IL-2, whereas 16% of the CD45.2+ cells were IL-2 producers in the mice injected with Ctrl cells (Fig. 5 B). Therefore, Blimp-1 attenuates CD4+ T cell proliferation and IL-2 production upon antigen-specific TCR stimulation in vivo (Fig. 5).
###end p 35
###begin p 36
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fos</italic>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 711 714 711 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 744 745 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Thus, this study demonstrates that Blimp-1 represses IL-2 production after T cell activation and shows that the molecular mechanism responsible depends, at least in part, on Blimp-1-dependent repression of Il2 and Fos transcription. Furthermore, we identify Blimp-1 response elements in these two genes. The conclusion that Blimp-1 represses IL-2 transcription is supported by several observations: (a) Blimp-1-expressing cells do not express IL-2 protein at detectable levels; (b) Blimp-1 mRNA induction correlates with IL-2 mRNA down-regulation; (c) IL-2 protein and steady-state mRNA are elevated in Blimp-1-deficient CD4+ T cells; and (d) endogenous Blimp-1 specifically binds to a regulatory region in the Il2 gene in activated primary CD4+ T cells.
###end p 36
###begin p 37
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
This establishes Blimp-1 as an important component in a recently described IL-2 autoregulatory loop (19) that operates in vivo to control the development and magnitude of T cell effector responses, and it confirms and extends the suggestion of Gong and Malek, that Blimp-1 plays an important role in IL-2 autoregulation (12).
###end p 37
###begin p 38
###xml 164 170 164 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 175 183 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 571 577 571 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 680 686 680 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
Interestingly, after activation in vitro, IL-2 production in Blimp-1-deficient T cells eventually decreases, although more slowly than in Blimp-1-sufficient cells (Fig. 1 and Fig. 3 A). Thus, mechanisms in addition to Blimp-1 are apparently present for IL-2 down-regulation. Nonetheless, Blimp-1 is important physiologically for IL-2 repression because lack of Blimp-1 results in increased IL-2 production upon antigen immunization in vivo. Increased levels of IL-2 produced by CKO cells are associated with increased proliferation both in vitro and in vivo (Fig. S1 and Fig. 5), and with increased resistance to cytokine deprivation-induced cell death after activation in vitro (Fig. 2). Thus, deregulation of IL-2 production in the Blimp-1 CKO mice is likely to contribute to the aberrant T cell homeostasis and the inflammatory phenotype observed in these mice.
###end p 38
###begin title 39
MATERIALS AND METHODS
###end title 39
###begin title 40
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 40
###begin p 41
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 90 99 90 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/flox</sup>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 237 246 237 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/flox</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 352 361 352 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/flox</sup>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 750 751 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">Mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
C57BL/6 (B6) and B6 CD45.1 congenic mice were purchased from The Jackson Laboratory. Prdm1flox/flox (3) were backcrossed 10 times with B6 mice, and then crossed with B6CD4-Cre mice, which were purchased from Taconic, to generate B6 Prdm1flox/floxCD4-Cre+ (Blimp-1CKO) and Prdm1+/+ CD4-Cre+ (Control). For some in vitro experiments, mixed B6 x 129 Prdm1flox/floxLck-Cre Prdm1+/+Lck-Cre (10) were also used. Mice bearing a BAC transgene-encoding membrane-target EGFP (mEGFP) under the control of Blimp-1 regulatory elements (Blimp-1 EGFP) (7) were a gift from M. Nussenzweig (The Rockefeller University, New York, NY) and were used as a reporter of Blimp-1 mRNA expression. In these mice, EGFP expression closely recapitulates Blimp-1 mRNA expression (7). For some experiments, spleen cells from Blimp-1 reporter mice were provided by S. Kaech's laboratory (Yale University, New Haven, CT). All mice were maintained in a specific pathogen-free animal facility at Columbia University and handled in accordance with the institutional guidelines. Animal experiments were approved by the Institutional Animal Care and Use Committee at Columbia University.
###end p 41
###begin title 42
Cell isolation, stimulation, and IL-2 production.
###end title 42
###begin p 43
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 345 346 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 370 375 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 375 378 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 386 387 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 391 396 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 396 399 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 407 408 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 546 547 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1175 1176 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 568 575 <span type="species:ncbi:9031">chicken</span>
Naive CD4+ (CD44lo) cells were sorted using a FACSAria fluorescent cell sorter (BD Biosciences). Routinely, purity of all cell preparation was >90%. For Blimp-1 ChiP experiments, naive CD4+ T cells were purified by negative selection using FITC-labeled antibodies and alphaFITC magnetic beads. The negatively isolated fraction contained >90% CD4+ cells. Naive B6 OT2-TG Prdm1F/F CD4-Cre+ or Prdm1+/+ CD4-Cre+ cells were stimulated in 48-well plates at a 1:1 ratio with APC (T cell-depleted and mytomycin-treated spleen cells) in a total of 5 x 105 cells per well with chicken OVA peptide (OVA 323-339; BP10-910 H2N-ISQAVHAAHAEINEAGR-OH; New England Peptide) for 3 d. IL-2 production was determined after incubation with 10 mug/ml Brefeldin A (BFA; Sigma-Aldrich) for the last 2 h of culture. When indicated, restimulation was done with 50 ng/ml PMA and 500 ng/ml ionomycin (both from Sigma-Aldrich) for 4 h, with BFA added in the last 2 h. IL-2 was detected by intracellular staining in combination with surface CD4 (both antibodies from BD Biosciences). Cells were analyzed in a LSRII flow cytometer (BD Biosciences). IL-2 staining was evaluated exclusively in the live, CD4+ gated lymphocytes.
###end p 43
###begin title 44
Simultaneous detection of Blimp-1 expression and IL-2 production.
###end title 44
###begin p 45
###xml 591 599 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 287 293 <span type="species:ncbi:9986">rabbit</span>
To evaluate IL-2 expression in Blimp-1-EGFP reporter cells, total spleen cells were stimulated with 1 mug/ml soluble alphaCD3 and 0.5 mug/ml alphaCD28 (both from BioExpress) with or without rHuIL-2 (QIAGEN). GFP expression was detected in permeabilized cells using an alphaGFP antibody (rabbit alphaGFP; Rockland Immunochemicals, Inc.) added simultaneously with the alphaIL-2 antibody. The alphaGFP antibody specifically stained GFP produced under the stimulation of the Blimp-1 transgenic promoter, as no staining was detected in nontransgenic cells stimulated and stained in the same way (Fig. 1 C).
###end p 45
###begin title 46
Quantitative real-time PCR.
###end title 46
###begin p 47
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 785 787 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 789 791 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
For detection of Blimp-1, IL-2, and Fos mRNAs, naive CD4+ T cells were stimulated with 5 mug/ml plate-bound alphaCD3, 2.5 mug/ml mug/ml alphaCD28, and 25 U/ml IL-2 for various time points. Total mRNA was isolated using TRIzol reagent (Life Technologies) according to the manufacturer's instructions. Reverse transcription was performed on equal amounts of RNA for each sample using SuperScript III (Invitrogen). SYBR Green incorporation quantitative real-time PCR was performed using a FastStart SYBR Green mix (Roche) in the ABI7400 Sequence Detection System (Applied Biosystems). Primers used were as follows: IL-2 forward, 5'-AGCAGCTGTTGATGGACCTA-3'; IL-2 reverse, 5'-CGCAGAGGTCCAAGTTCAT-3' (designed using Primer 3 software). Primers for Blimp-1 and Fos were previously described (10, 25).
###end p 47
###begin title 48
ChIP.
###end title 48
###begin p 49
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 243 249 <span type="species:ncbi:9986">rabbit</span>
ChIP assays were performed as previously described (25), with few modifications. Cells were fixed with 1.1% paraformaldehyde for 10 min at room temperature. Sonicated chromatin from 4-5 x 107 cells was immunoprecipitated with 25 mul of either rabbit alphaBlimp-1 polyclonal antibody serum (clone 267) or preimmune serum as a control. SYBR Green incorporation quantitative real-time PCR was performed in DNA recovered from immunoprecipitation and input samples (primers sequences in Table S2, available at ). Fold enrichment was calculated dividing the percentage of input values obtained with alphaBlimp by the one obtained with Ctrl antibody. Analysis of sequence homology and identification of putative Blimp-1 consensus sites were performed using the ECR browser () and rVista 2.0 software. Genomic sequences were obtained from Ensembl.
###end p 49
###begin title 50
In vivo immunization.
###end title 50
###begin p 51
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm1</italic>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 444 445 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 676 677 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
CFSE-labeled naive B6 OT2-TG Prdm1F/F CD4-Cre+ or Prdm1+/+ CD4-Cre+ cells (CD45-2+) (1 x 106) were transferred (i.v.) to allotype-marked congenic recipients (C57Bl/6 SJ CD45.1). 2 d after cell transfer, mice were immunized i.v. with GMCSF-bone marrow-derived dendritic cells matured with LPS and IL-4 and pulsed with the cognate peptide (1 mug/ml OVA 334-339). 5 d later, lymph nodes were recovered and CFSE dilution was evaluated in the CD45.2+ cells. Alternatively, freshly harvested total lymph node cell suspensions were restimulated in vitro with PMA and ionomycin (with BFA added in the last 2 h), and IL-2 production was evaluated at the single-cell level in the CD45-2+ population by intracellular cytokine staining.
###end p 51
###begin title 52
Cytokine deprivation cell death assay.
###end title 52
###begin p 53
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Naive CD4+ T cells were stimulated (as described in Quantitative real-time PCR) for RNA isolation and cultured for 5 d. On day 5, cells were washed extensively in complete RPMI medium and replated at the same initial density in the presence (50 U/ml) or absence of rHuIL-2. The percentage of live cells (7-AAD-/Annexin V-) was assessed 1, 2, or 3 d later.
###end p 53
###begin title 54
Online supplemental material.
###end title 54
###begin p 55
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2</italic>
Fig. S1 shows that lack of Blimp-1 results in increased proliferation upon antigen-specific stimulation in vitro. Table S1 shows the putative Blimp-1 binding sites at the Il2 gene. Table S2 lists the primers used for Blimp-1 ChIP at the Il2 gene. The online version of this article is available at .
###end p 55
###begin p 56
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
We thank Dr. H. Gu for advice and for critically reading the paper; the Calame laboratory for advice; Dr. Boris Reizis and his laboratory for advice (especially Jose Galan-Caridad and Michele Caton for advice on ChIP and i.v. injections). We thank Kristie Gordon and the staff at Columbia FACS core facility for sorting. We are grateful to Dr. Michel Nussenzweig for the Blimp-1 reporter mice and to Rachel Rutshauser and Susan Kaech for advice and reagents for Blimp-1 reporter mice experiments. We thank QIAGEN for the gift of rHuIL-2.
###end p 56
###begin p 57
This work was supported by RO1-AI50659 and RO1-AI43576 to K. Calame.
###end p 57
###begin p 58
The authors have no conflicting financial interests.
###end p 58

